Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
TXMD compared with MREO: revenue, margins and what each company keeps, and the suppliers and customers both name
TXMD
TherapeuticsMD, Inc.
Change
Mkt cap
Revenue
Revenue
MREO
Mereo BioPharma Group plc
Change
Mkt cap
Revenue
Revenue
vs
Compare
TXMD
TherapeuticsMD, Inc.
vs
MREO
Mereo BioPharma Group plc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
TXMD, solid
MREO, dashed
TXMD
TherapeuticsMD, Inc.
Change
1.66
▼
−2.92%
· post 1.66
Mkt cap
$20.3M
Revenue
$869,000
Q2 FY26
Revenue
$3M
FY25
MREO
Mereo BioPharma Group plc
Change
0.28
▲
+0.46%
· post 0.28
Closed
Nov 6 '26
Mkt cap
$45.2M
Revenue
$500,000
Q2 FY25
Revenue
—
vs
Compare
Closed
Nov 6 '26
TXMD
TherapeuticsMD, Inc.
vs
MREO
Mereo BioPharma Group plc
1.66
▼
−2.92%
post 1.66
Price
0.28
▲
+0.46%
post 0.28
$20.3M
Mkt cap
$45.2M
Q2 FY26
$869,000
Revenue
$500,000
Q2 FY25
FY25
$3M
Revenue
—
Change
Change
TXMD
1.66
▼
−2.92%
vs
MREO
0.28
▲
+0.46%
Closed
Nov 6 '26